Integrase inhibitor–based antiretroviral therapy drives gut microbiota remodeling and immune recovery in HIV infection - Top-Institutions - MDSpire

Integrase inhibitor–based antiretroviral therapy drives gut microbiota remodeling and immune recovery in HIV infection

  • By

  • Banu Karaca

  • Alper Şener

  • Figen Kaptan

  • Deniz Ece

  • Bahar Örmen

  • Ayse Caner

  • May 12, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Infectious Diseases Clinic
    Infectious Diseases Clinic

    Unknown, Unknown

    Key Differentiators

    • Infectious Disease

  • #2

    HIV Prevention Trials Network
    HIV Prevention Trials Network

    Unknown, Unknown

    Key Differentiators

    • Infectious Disease

Original Source(s)

Integrase inhibitor–based antiretroviral therapy drives gut microbiota remodeling and immune recovery in HIV infection

  • by Banu Karaca, Alper Şener, Figen Kaptan, Deniz Ece, Bahar Örmen, Ayse Caner

  • May 12, 2026

Related Content

Alterations in Gut Microbiota and Metabolomic Profiles in Myasthenia Gravis: Findings from 16S rRNA Sequencing and Untargeted Metabolomics Analysis

Antibiotic Falls Short in Disc-Related Back Pain

A randomized trial found no greater pain reduction vs placebo, but questions remain about patients with type 1 Modic changes.

Exploring the Gut-Lung Connection in Pediatric Asthma: From Early Microbial Influences to Tailored Microbiome-Based Therapies—A Comprehensive Review